Omid V. Ebrahimi

Double PhD Candidate
Image of Omid V. Ebrahimi
Norwegian version of this page
Room S02-16
Username
Visiting address Forskningsveien 3A Harald Schjelderups hus 0373 OSLO
Postal address Postboks 1094 Blindern 0317 OSLO

Academic interests

  • Personalized psychological treatment

  • Psychopathology

  • Idiography vs. nomothesis

  • Integrative research methods – combination of process- and outcome research

  • Complex systems, graph theory and network models

  • Philosophy of Science

  • Integrative therapies

  • Psychological effects of non-pharmacological epidemiological interventions during pandemics (i.e., COVID-19)

Project

Graduate student at the Norwegian Double PhD Program (“Prosjekt Dobbelkompetanse”) at the University of Oslo and Modum Bad Psychiatric Hospital and Research Center. The project utilizes the complex systems- and the network paradigm to investigate psychopathology on two levels; cross-sectionally across specified groups of individuals, and longitudinally through the intensive study of the individual.

Supervisors: Sverre Urnes Johnson, Asle Hoffart and Ole Andre Solbakken.

Background

  • Cand.psychol. (Clinical Psychologist), Faculty of Psychology, University of Bergen, spring 2019.

  • Visiting scholar at Center for Anxiety & Related Disorders working in team led by Dr. Todd J. Farchione and Dr. David H. Barlow.

  • University of California, Berkeley –The Berkeley Clinical Science Practicum Program (2019).

  • The University of Hong Kong (HKU), 2016.

  • Norwegian University of Science and Technology (2010).

Teaching

Other associations

  •  Modum Bad Psychiatric Hospital and Research Center.
  • Clinical Psychologist specializing in adult psychopathology and trauma-related disorders at the Trauma Polyclinic Modum Bad, Oslo.
  • Clinical Psychologist at the Institute of Psychological Guidance (IPR).
Tags: Clinical Psychology, Methodology, Psychopathology, Complex Systems, Psychometrics

Publications

Published Jan. 16, 2020 11:40 AM - Last modified Apr. 21, 2021 8:30 AM